NewAmsterdam Pharma Co N.V.
NAMS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001936258
In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 4 sales; 194 institutions reported holding it in 13F filings for Q2 2026, worth $4.13B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
Other share classesNAMSW
Q4 2023 vs. Q3 2023
How the institutions holding NewAmsterdam Pharma Co N.V. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 35 | 32 | −3 |
| Shares | 50.2M | 61.9M | +11.7M (+23.4%) |
| Value | $464.1M | $691.4M | +$227.3M (+49.0%) |
New holders (4)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FCPM III Services B.V. | 11,831,461 | $132.2M | 38.94% |
| Goldman Sachs Group Inc | 1,384,321 | $15.5M | 0.00% |
| Opaleye Management Inc. | 265,388 | $2.96M | 0.80% |
| UBS Group AG | 800 | $8.94K | 0.00% |
Sold out (7)
Institutions that held NewAmsterdam Pharma Co N.V. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Janus Henderson Group PLC | 434,912 | $3.97M |
| UBS Oconnor LLC | 45,000 | $416.3K |
| Alyeska Investment Group, L.P. | 44,432 | $411.0K |
| Maven Securities LTD | 25,000 | $231.3K |
| Parkwood LLC | 20,209 | $187.0K |
| CIBC Private Wealth Group, LLC | 13,000 | $120.3K |
| JPMorgan Chase & Co | 2,622 | $24.3K |